Sign in

CIK 0001674416 · Large accelerated filer

CRISPR Therapeutics AG

Sign in to watch
Ticker
CRSP
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Switzerland
Entity type
operating
EIN
473173478
Phone
6173154600
Business address
BAARERSTRASSE 14, ZUG, Switzerland
Former names
CRISPR Therapeutics AG
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$4,881,673
in 7 filings, $1.5M under 10b5-1 plans

Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 60 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-03-01 Kulkarni Samarth Chief Executive Officer Shares withheld for taxes −748 $39.97 $30K 166,542
2019-02-25 Novak Rodger President Sale −14,780 $40.00 $591K 1,033,227
2019-01-09 Novak Rodger President Sale −82,690 $35.01 $2.9M 1,048,007
2019-01-08 Novak Rodger President Sale −17,310 $35.09 $607K 1,130,697
2019-01-02 Klein Lawrence Otto Chief Business Officer Grant or award +20,000 $29.87 $597K 20,000
2019-01-02 Klein Lawrence Otto Chief Business Officer Grant or award · Stock Option (Right to Buy) +20,000 20,000
2018-12-27 Vertex Pharmaceuticals (Europe) Ltd 10% owner Purchase +27,461 $24.95 $685K 5,380,940
2018-12-26 Vertex Pharmaceuticals (Europe) Ltd 10% owner Purchase +12,737 $24.89 $317K 5,353,479
2018-12-24 Vertex Pharmaceuticals (Europe) Ltd 10% owner Purchase +2,603 $22.91 $60K 5,275,345
2018-12-24 Vertex Pharmaceuticals (Europe) Ltd 10% owner Purchase +11,742 $23.18 $272K 5,287,087
2018-12-24 Vertex Pharmaceuticals (Europe) Ltd 10% owner Purchase +53,655 $24.97 $1.3M 5,340,742
2018-12-21 Vertex Pharmaceuticals (Europe) Ltd 10% owner Purchase +22,742 $22.58 $513K 5,272,742
2018-12-18 EMSTER KURT VON Director Sale −62,925 $29.70 $1.9M 1,171,268
2018-12-18 EMSTER KURT VON Director Sale −69,925 $29.70 $2.1M 1,164,268
2018-12-17 EMSTER KURT VON Director Sale −3,009 $33.17 $100K 1,234,193
2018-12-07 Kulkarni Samarth Chief Executive Officer Option exercise +21,500 $1.81 $39K 167,290
2018-12-07 Kulkarni Samarth Chief Executive Officer Option exercise · Stock Options (Right to Buy) −21,500 243,058
2018-12-01 Kulkarni Samarth Chief Executive Officer Shares withheld for taxes −741 $38.33 $28K 145,790
2018-11-21 CELGENE CORP /DE/ 10% owner Sale −80,000 $19.25 $1.5M 4,173,019
2018-09-01 Kulkarni Samarth Chief Executive Officer Shares withheld for taxes −741 $56.67 $42K 146,531

Page 48 of 62 · 1,221 trades